. Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia. J Neurol. 2007 Feb;254(2):154-9. Epub 2007 Feb 21 PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(57)
516.6 ± 329.8
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
Aβ42
(CSF)
CTRL-
Other Controls
(47)
1012.8 ± 361.9
pg/mL
ELISA;
Innotest;
Innogenetics
Aβ42
(CSF)
VaD-
Possible VaD
(21)
809 ± 461.8
pg/mL
ELISA;
Innotest;
Innogenetics
Román et al., 1993
tau-total
(CSF)
AD
(57)
496.9 ± 279.9
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
CTRL-
Other Controls
(47)
350.9 ± 154
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
VaD-
Possible VaD
(21)
431.2 ± 264.5
pg/mL
ELISA;
Innotest;
Innogenetics
Román et al., 1993

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.